OnKure Therapeutics (OKUR) Total Liabilities (2020 - 2026)

OnKure Therapeutics (OKUR) has reported Total Liabilities for 7 consecutive years, with $7.2 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Total Liabilities fell 8.34% year-over-year to $7.2 million; the trailing twelve-month figure through Jun 2026 stood at $7.2 million (down 8.34% YoY), and the FY2025 full-year result was $5.9 million, down 46.45% from the prior year.
• Total Liabilities slipped to $7.2 million in Q2 2026 per OKUR's latest filing, from $14.3 million in the prior quarter.
• Across five years, Total Liabilities topped out at $15.5 million in Q2 2023 and bottomed at $1.8 million in Q2 2024.
• Historically, Total Liabilities has averaged $8.8 million across 5 years, with a median of $8.7 million in 2022.
• The sharpest annual moves came in 2024 and 2025: Total Liabilities sank 88.09% in 2024, then surged 327.71% in 2025.
• Over 5 years, Total Liabilities stood at $8.2 million in 2022, then decreased by 5.61% to $7.8 million in 2023, then surged by 42.94% to $11.1 million in 2024, then plunged by 46.45% to $5.9 million in 2025, then grew by 22.11% to $7.2 million in 2026.
• According to Business Quant data, Total Liabilities over the past three periods registered $7.2 million, $14.3 million, and $5.9 million for Q2 2026, Q1 2026, and Q4 2025 respectively.